All I know is that my CEO has not provided guidance and I'd say we're close to take off. Sorry but I definitely feel like the narrative and enthusiasm regarding lympro has changed. Personally I am not expecting any traditional partner anytime soon. I'm not enthused about the possibility of acquiring at moment considering cash has dwindled I'd prefer they go to McDonald's for their office toilet paper supply. Especially considering the only lympro guidance for upcoming year I have seen will cover 2 salaries. Makes me wonder if they are in a scurry to acquire a new shorter term revenue generating asset to replace the lympro dud. Hope I am proved wrong.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links